← Eichor
Study identifier: NCT06932172 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Artificial Intelligent Decision Support for Skin Cancer Diagnostics in Primary Care

Condition: Skin Cancer  ·  Sponsor: Linkoeping University

PhaseNA
Planned participants3000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Background: Artificial intelligence has in numerous studies shown high accuracy in detecting skin cancer when trained on various databases of dermatoscopic images. However, there are very few prospective studies conducted in real clinical settings directed at patients seeking healthcare for assessment of skin lesions, and nosuch studies at all in primary care, where the majority of patients are managed. Project aim: To study the accuracy, reliability, and clinical utility of an AI-based decision support system (Dermalyser), developed for primary care, in distinguishing skin cancer from benign lesions. Method: Cluster-randomized controlled trial at approx. 30 primary care centers in Sweden, Germany, Scotland, the Netherlands and Australia. At study start, the participating primary care centres in each country are equally randomised to either be enabled to use the Dermalyser (intervention phase) or to assess patients according to the standard clinical procedure (control phase). When half of the intended sample size (i.e. 1500 of 3000 participants) have been included, the primary care centres switch phase from intervention to control, or vice versa. During the intervention phase, the physicians may use (if found indicated) Dermalyser as a part of their clinical evaluation, whereas during the control phase the physicians follow their ordinary diagnostic routine without support from Dermalyser. This will direct the participants to either an intervention or a control cohort. Both…

This description comes directly from the study's public registry record.

Talk to the study team

Magnus Falk, Professor  ·  +46708106176  ·  magnus.falk@liu.se

Panos Papachristou, MD, PhD  ·  +46702298892  ·  panos.papachristou@ki.se

Always discuss trial participation with your own doctor first.

Locations (8)

Finspång Primary Healthcare CentreFinspång, Docent, SwedenRecruiting
Valla Primary Healthcare CentreLinköping, Docent, SwedenRecruiting
Kärna Primary Care CentreLinköping, Docent, SwedenRecruiting
Mjölby Primary Care CentreMjölby, Docent, SwedenRecruiting
Vikbolandet Primary Care CentreNorrköping, Docent, SwedenRecruiting
Åby Primary Healthcare CentreNorrköping, Docent, SwedenRecruiting
Skärvet Primary Healthcare CentreVaxjo, Docent, SwedenRecruiting
Ekholmen Primary Healthcare CentreLinköping, SwedenRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06932172